PRKCSH and lung carcinoma: Here, we report for the first time that increased expression of PRKCSH in lung cancers is associated with loss of NK cell-mediated antitumor effects via adaptation to the TNFSF response, as clearly evidenced by the results of various experiments on tumor sphere formation, cell death, and in vivo tumorigenesis.